Amgen’s $27.8 Billion Deal for Horizon Therapeutics Clears Key Hurdle
The Federal Trade Commission said it had agreed to end its legal challenge of the $27.8 billion deal. The pact...
Amgen
FTC Pauses Challenge to Amgen’s $27.8 Billion Deal for Horizon Therapeutics
The move gives the agency time to weigh a settlement that would allow the deal to close with conditions. Source...
FTC Moves to Block Amgen’s $27.8 Billion Deal for Horizon Therapeutics
ShareListen(2 min) Source link
Amgen Agrees to Deal to Buy Horizon Therapeutics
BusinessThe U.S. biotechnology company will pay $116.50 for each Horizon share Source link
Pfizer, Uber and Starbucks Highlight Another Busy Earnings Week
Pfizer Inc., PFE 3.69% Uber UBER -1.15% Technologies Inc. and Starbucks Corp. SBUX 2.13% are among the heavyweights headlining another...
WSJ News Exclusive | Pfizer in Advanced Talks to Buy Global Blood Therapeutics for About $5 Billion
Pfizer Inc. PFE -1.18% is in advanced talks to buy Global Blood Therapeutics Inc., GBT 33.03% the maker of a...
Starbucks, Uber, CVS to Report Earnings Amid Shrinking Economy
About 30% of S&P 500 companies are slated to report earnings in the coming week, according to FactSet. Two Dow...
